1. Role of YourMD Online, LLC

YourMD Online, LLC is a technology services company, not a medical practice. YourMD does not employ physicians or other clinicians, does not itself provide medical advice, diagnosis, or treatment, and does not dispense medication. All clinical services accessed through this platform are delivered exclusively by independent licensed healthcare providers practicing through United Medical Group and its affiliated physicians ("Providers").

To the maximum extent permitted by law, YourMD Online, LLC disclaims all liability for any medical decision, diagnosis, treatment, prescription, dispensing, clinical outcome, or provider conduct occurring in connection with the platform.

2. Nature and Limitations of Telehealth

You acknowledge and agree that:

• Telehealth involves the delivery of healthcare using electronic communications (video, audio, chat, email, asynchronous messaging, and uploaded data).
• Telehealth cannot fully replicate an in-person encounter. Providers cannot perform a physical examination, may not have access to complete records, and are dependent on the accuracy and completeness of the information you supply.
• Potential limitations include, without limitation: inability to detect findings that would normally be identified on physical exam, delayed diagnosis, misdiagnosis, technology or transmission failure, and unauthorized interception of data despite commercially reasonable safeguards.
• Telehealth is not appropriate for medical emergencies. If you believe you are experiencing a medical emergency (including but not limited to chest pain, difficulty breathing, stroke symptoms, suicidal ideation, severe bleeding, or loss of consciousness), you must call 911 or go to the nearest emergency department.
• A Provider may determine, in their sole clinical judgment, that telehealth is not appropriate for your condition and may refer you to in-person care, decline to prescribe, or discontinue treatment at any time.
• Services are only available in states where the treating Provider is actively licensed. You must be physically located in a licensed state at the time of any encounter.

2A. State-Specific Telehealth Rules

YourMD Providers are licensed in Nevada, Washington, Oregon, and Wisconsin. You must be physically present in one of these states at the time of each encounter. Additional state-specific rules apply:

• Nevada (NRS 629.515; NAC 630): Telehealth establishes a valid provider-patient relationship without a prior in-person visit, provided the Provider performs an appropriate evaluation meeting the standard of care. Controlled substances are not prescribed through telehealth on this platform. Patients have the right to refuse telehealth and request in-person care where available.
• Washington (RCW 18.134; WAC 246-919): The Provider must be licensed in Washington at the time of service, must meet the Washington standard of care, and must use technology that meets HIPAA security requirements. Patients are informed of the Provider's name, license number, and credentials prior to the encounter. Telemedicine services comply with the Washington Telemedicine Act.
• Oregon (ORS 677.493; OAR 847-025): Oregon Medical Board rules require an established provider-patient relationship based on a medically appropriate evaluation. Patients must be informed of the limitations of telemedicine, provided a method for emergency contact, and given instructions for follow-up care.
• Wisconsin (Wis. Stat. § 448.30; Wis. Admin. Code Med 24): The treating Provider must hold an active Wisconsin medical license at the time of the encounter. Wisconsin requires informed consent for medical treatment, including disclosure of the nature and purpose of treatment, known risks and complications, reasonable alternatives, and prognosis if treatment is refused. Wisconsin law applies to all encounters with patients physically present in Wisconsin at the time of service.
• All states: You must provide a current physical address and confirm your location at the start of each encounter. If you travel to a state where your Provider is not licensed, new consultations, dose adjustments, and new prescriptions require you to be physically located in a licensed state (NV, WA, OR, WI) at the time of the encounter. Active medication subscriptions will continue to ship to your address on file regardless of your temporary travel location. If you relocate permanently to a non-licensed state, your subscription will be discontinued at the end of the current billing cycle and you will be responsible for transitioning care to a provider licensed in your new state. You are solely responsible for accurately reporting your location; misrepresentation may result in termination of service and is a material breach of this Agreement.

Laws and regulations change. To the extent any state-specific rule conflicts with this Agreement, the state rule controls for encounters occurring in that state, but only as to that conflict.

3. No Controlled Substances — No Opioids

YourMD Providers do not prescribe controlled substances of any kind through this platform, including but not limited to opioids, benzodiazepines, stimulants, hypnotics, testosterone, anabolic steroids, human growth hormone (HGH), ketamine, or any Schedule I–V controlled substance as defined by the federal Controlled Substances Act or by state law. Requests for such medications will be declined and may be logged for safety and compliance review.

4. Direct-to-Consumer (DTC) Subscription Program

The platform offers optional DTC subscription programs for non-controlled, commonly-prescribed medications in the following categories ("Subscription Services"):

• Weight Management: FDA-approved, brand-name GLP-1 and GIP/GLP-1 medications for chronic weight management — Wegovy® (semaglutide), the Wegovy® pill (oral semaglutide), Zepbound® (tirzepatide), and Foundayo™ (orforglipron) — prescribed and routed exclusively to manufacturer-direct pharmacies. The medication is billed separately by NovoCare® (Novo Nordisk) or LillyDirect™ (Lilly), or by your insurance; YourMD does not ship GLP-1 medications. Ozempic®, Rybelsus®, and Mounjaro® are FDA-approved for type 2 diabetes, not for weight management. YourMD does not prescribe compounded semaglutide, compounded tirzepatide, or any compounded GLP-1 medication.
• Sexual Wellness (Erectile Dysfunction): FDA-approved generic sildenafil and tadalafil tablets (PDE5 inhibitors), and compounded sublingual sildenafil/tadalafil troches (a compounded preparation, not FDA-approved).
• Hair Restoration: Oral finasteride 1 mg (with minoxidil 5% if recommended), minoxidil 5%, compounded topical finasteride + minoxidil with or without tretinoin (a compounded preparation, not FDA-approved), and dutasteride (physician-selected, off-label).
• Dermatology: Tretinoin and compounded topical formulations, including custom tretinoin combinations and melasma treatment.
• Vitality & Energy: B12 + MIC injections, vitamin protocols, and vitamin D3 + K2.
• Women's Sexual Health: Addyi® and Vyleesi® (FDA-approved), and compounded PT-141 troches alone or with oxytocin.
• Peptide Therapy: Compounded PT-141 (bremelanotide) troches. Sermorelin is on hold and not currently prescribed while we confirm pharmacy eligibility. YourMD does not prescribe BPC-157, TB-500, KPV, MOTS-c, GHK-Cu, AOD-9604, CJC-1295, ipamorelin, GHRP-2 or other growth-hormone secretagogues, or the Wolverine/GLOW/KLOW blends. Compounded peptide preparations are not FDA-approved and are prescribed based on limited clinical evidence. Patients accept the specific risks disclosed in the treatment acknowledgment before receiving these products. See Section 4.1 for peptide-specific risk disclosures.
• Longevity & Optimization: Extended-release metformin, rapamycin (sirolimus), and NAD+ injections, prescribed off-label for preventive and metabolic health applications. YourMD does not prescribe testosterone.
• Women's Hormone Health (anticipated): Bioidentical progesterone, estradiol, and related compounded hormone preparations. This category is in development and not yet active.

Subscription Services require a telehealth consultation and clinical evaluation before any medication is prescribed. Purchase of a subscription does not guarantee that a Provider will prescribe the requested medication. A Provider may decline to prescribe based on medical history, contraindications, or clinical judgment, with no further obligation.

4.1 Medication Risks and Informed Consent

All prescription medications carry risk. Before purchasing or accepting any Subscription Service, you acknowledge and accept the following category-level risks, which are not exhaustive and do not substitute for the medication guide or the Provider's individualized counseling:

• GLP-1 / GIP-GLP-1 agonists (semaglutide, tirzepatide): nausea, vomiting, diarrhea, constipation, abdominal pain, injection-site reactions, fatigue, pancreatitis, gallbladder disease, acute kidney injury from dehydration, hypoglycemia (especially when combined with insulin or sulfonylureas), boxed warning for thyroid C-cell tumors including medullary thyroid carcinoma (MTC) — contraindicated in patients with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2), and possible fetal harm. YourMD prescribes only FDA-approved branded GLP-1 medications dispensed through manufacturer-direct pharmacies. Compounded semaglutide and tirzepatide are not prescribed through this platform.
• PDE5 inhibitors (sildenafil, tadalafil): headache, flushing, dyspepsia, nasal congestion, back pain, visual disturbance, priapism (prolonged erection > 4 hours — a medical emergency), sudden hearing loss, non-arteritic anterior ischemic optic neuropathy (NAION), and life-threatening hypotension when combined with nitrates or guanylate cyclase stimulators — use is absolutely contraindicated with nitrates in any form. Not recommended within 6 months of MI, stroke, or life-threatening arrhythmia.
• 5-alpha reductase inhibitors (finasteride): decreased libido, erectile dysfunction, ejaculatory disorder, gynecomastia, depression and suicidal ideation (rare), persistent sexual side effects ("post-finasteride syndrome") in some patients even after discontinuation, ~50% reduction in measured PSA that must be accounted for in prostate cancer screening, and teratogenicity — pregnant women must not handle crushed or broken tablets.
• Topical minoxidil: scalp irritation, pruritus, contact dermatitis, unwanted facial hair growth, initial shedding phase, reversal of benefit after discontinuation, and rare systemic effects including tachycardia and hypotension.
• Topical tretinoin: skin dryness, peeling, erythema, photosensitivity, initial acne "purge," and potential fetal harm (pregnancy should be avoided during use).
• Vitamin D3 (high-dose), B12, NAD+: rare hypercalcemia with prolonged high-dose vitamin D, injection-site reactions, and hypersensitivity reactions.
• Peptide therapy (PT-141 / bremelanotide compounded troche): The compounded PT-141 troche is NOT FDA-approved; it is a compounded preparation and an alternative dosage form, not the same as or equivalent to Vyleesi®. PT-141 may cause nausea (reported in up to 40% of patients), flushing, headache, transient blood pressure elevation, and skin hyperpigmentation; it is contraindicated in patients with uncontrolled hypertension. Onset and long-term safety data for compounded troches are limited. You accept these risks when electing peptide therapy. BPC-157 and the other hard-blocked peptides listed in Section 4 are not prescribed through this platform; they cannot legally be compounded for patients. Sermorelin is on hold and not currently prescribed while we confirm pharmacy eligibility.

You acknowledge that you have disclosed to your Provider every relevant medical history item, current medication, supplement, allergy, and pregnancy status, and that any omission or misrepresentation may result in serious harm for which YourMD and the Provider disclaim all liability.

4.2 Compounded Medication Disclosure (Non-GLP-1)

Certain Subscription Services (including sublingual troches for erectile dysfunction, PT-141 troches, NAD+ and B12 + MIC injections, and custom topical formulations) are dispensed as patient-specific compounded preparations by a licensed 503A compounding pharmacy (for example Hallandale Pharmacy or Valiant Compounding Pharmacy); the dispensing pharmacy is named on your prescription label. These compounded preparations are not FDA-approved finished drug products and do not undergo the same premarket review as manufactured products. You acknowledge that compounded medications:

• Are prepared specifically for you based on your Provider's prescription
• May differ in appearance, delivery mechanism, or concentration from commercially available equivalents
• Carry risks inherent to compounding including variability in potency, sterility, and formulation

GLP-1 medications (semaglutide, tirzepatide, orforglipron) are not available as compounded products through YourMD. All GLP-1 prescriptions are for FDA-approved branded medications dispensed by manufacturer-direct pharmacies only.

4.3 Billing, cancellation and refunds

A completed consultation means the clinician has completed the patient evaluation, communicated the assessment and care plan to the patient, and submitted the encounter note. This applies to video, phone, live chat and asynchronous consultations. For async care, the written clinical response must be delivered through the patient portal. Intake submission, payment, scheduling, opening a chart, preliminary review or an unanswered call alone does not complete a consultation.

A completed consultation remains chargeable when the clinician determines that no prescription is appropriate or recommends in-person care. Payment purchases professional evaluation, not a prescription or a guaranteed result. We honor any more favorable refund promise in the terms accepted for the purchase.

We refund undelivered consultations, consultations prevented by practice or platform failure, duplicate or erroneous charges, and renewal charges made after a valid cancellation took effect. A missed or cancelled appointment does not by itself justify retaining the full visit fee. Any separate attendance fee must have been effective, disclosed and acknowledged before booking; the proposed $45 no-show policy is not activated by this page.

Subscription inclusions are stated in the selected plan and checkout. Medication, shipping and lab costs are included only when expressly listed; they are not included in care-only memberships. Acne Care covers physician care and monthly async updates; your chosen retail pharmacy and local lab bill you or your insurance separately. YourMD does not pay or reimburse those charges.

Cancel a subscription in the patient portal, by emailing support@yourmd.online, or by calling (702) 430-7801. Cancellation stops future renewals and carries no subscription cancellation, early-termination or reinstatement fee. Current-period refunds remain available for undelivered services and the exceptions in the Refund Policy. Separate appointment attendance fees are not subscription cancellation fees.

Existing subscribers keep the price for a paid term. We provide at least 90 days' advance notice before an increase to an existing subscriber's price, including a migration that increases it, and apply it no earlier than a subsequent renewal after that notice. A plan retirement without a price increase requires at least 60 days' notice. Other material billing-policy changes require at least 60 days' notice and do not apply retroactively. A longer notice or more favorable promise already accepted is honored.

Please contact support about billing errors so we can help promptly. Contacting us first is encouraged, not required to exercise lawful bank or card-issuer dispute rights. A good-faith dispute is not a breach of these terms and does not by itself trigger a penalty or loss of access to medical records. Do not wait for our response if an issuer deadline is approaching.

See the Refund Policy for refund exceptions, requests and processing times. These billing provisions replace conflicting chart-review-only, blanket final-sale and dispute-before-support restrictions on this page. Previously accepted more favorable terms remain honored.

4.4 Program Limitations

• Subscription Services are not a substitute for comprehensive primary care, specialist care, emergency care, or in-person follow-up.
• Subscription Services do not include diagnostic imaging, in-person procedures, vaccinations, or laboratory draws (orders may be placed but collection occurs at external facilities you select).
• Shipping of medication is performed by third-party pharmacies. YourMD does not warrant shipping times, carrier performance, or product condition after leaving the pharmacy.
• Pharmacy selection. YourMD reserves the right to select and change compounding pharmacy partners at any time without prior notice. Prescriptions may be routed to any pharmacy in our licensed partner network based on availability, geographic coverage, formulation requirements, and operational considerations. You may request a specific pharmacy, but fulfillment through that pharmacy is not guaranteed. If a pharmacy change affects your medication formulation or pricing, we will notify you before your next billing cycle.
• Insurance, HSA, and FSA. Insurance is not accepted for Subscription Services. Subscription fees are cash-pay. Consultation fees and prescription medications may be eligible for reimbursement from Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA) depending on your plan's eligible expense categories. YourMD does not guarantee HSA/FSA eligibility and recommends verifying with your plan administrator before purchase. YourMD can provide itemized receipts upon request to support reimbursement claims.
• YourMD reserves the right to discontinue, modify, or restrict any Subscription Service at any time, including for clinical, regulatory, or supply reasons, without further obligation.

4.5 Provider Referral Program

If you access the platform through a referral link or code from a healthcare provider, pharmacy, or other referral source, you acknowledge that: (a) the referring party does not receive financial compensation from YourMD for the referral; (b) your clinical care is provided independently by YourMD Providers without influence from the referring party; (c) any promotional discount applied to your account through a referral code is a patient benefit and is not contingent upon any payment to the referring party; and (d) we may track the referral source for internal analytics. Your relationship with the referring provider is separate from your relationship with YourMD. See the Referral Program Disclaimer for the complete compliance framework.

4.6 No Sale of Health Data

YourMD does not sell, rent, lease, or trade your personal health information or protected health information to any third party for advertising, marketing, or any commercial purpose. We do not permit third-party advertising trackers to access patient health data on our platform.

5. Eligibility

Services are currently available to individuals 18 years of age or older. Pediatric and adolescent care is not offered at this time and is planned as we grow our physician team. To use the platform, you must:

• Be 18 years of age or older.
• Be physically present in a state where the Provider is licensed at the time of each encounter.
• Have legal capacity to enter into this Agreement.
• Provide accurate identification and pass identity verification requirements where applicable (IAL2 document review).

6. Patient Responsibilities

You agree to:

• Provide complete, accurate, and current medical history, medications, allergies, and contact information.
• Promptly update records when information changes.
• Follow the Provider's instructions and follow-up recommendations.
• Report any adverse reaction, worsening symptom, or red-flag event immediately.
• Safeguard your login credentials and maintain the confidentiality of your account.
• Not share medication with any other person and not use medication outside the prescribed indication.
• Obtain laboratory tests and follow-up as directed by the Provider.

7. Fees, Pricing, and Payment

Consultation fees are currently priced at $60 for a new-patient first consultation, and for established patients $50 (video), $40 (audio), or $20 (chat) per session, subject to change. Chronic-care plans (diabetes, hypertension, cholesterol, heart failure) are priced separately at $99 initial, $49 follow-up, and $25 refill. Subscription pricing is shown in the table below and on the treatments page. You authorize YourMD and its payment processors to charge your designated payment method for all fees, applicable taxes, and shipping where relevant. Failed payments may result in suspension of services.

7.1 Current Subscription Pricing

All prices are in USD and billed monthly unless noted. There are no bundles: you subscribe to one plan per treatment category, and each plan is billed at its own price. GLP-1 medication is billed separately by NovoCare® or LillyDirect™ (or your insurance) and is not included in the GLP-1 plan fees.

Price increases for existing subscribers require at least 90 days' advance notice and apply only at a renewal after that notice; see section 4.3.

8. Intellectual Property

All content on the platform, including software, text, graphics, logos, and compiled clinical protocols, is owned by or licensed to YourMD Online, LLC and is protected by copyright, trademark, and other intellectual property laws. You are granted a limited, non-exclusive, non-transferable license to use the platform solely for receiving healthcare services. Any other use, including scraping, reverse-engineering, or redistribution, is prohibited.

9. Acceptable Use

You agree not to:

• Impersonate another person or misrepresent your identity.
• Upload malicious code, attempt to probe, scan, or test the vulnerability of the platform, or bypass security controls.
• Use the platform for any unlawful purpose or in violation of any federal, state, or local law.
• Harass, threaten, or abuse Providers, staff, or other users.
• Resell, redistribute, or transfer any medication obtained through the platform.

9a. YourMDRx Electronic Prescribing & Prior Authorization

Prescriptions issued by United Medical Group physicians are processed through YourMDRx, an e-prescribing platform operated by YourMD Online, LLC as the contracted technology platform for United Medical Group. The physician makes all prescribing decisions; YourMDRx is the tool used to transmit and manage those prescriptions.

Drug Safety Database

YourMDRx performs drug interaction and allergy contraindication checks using the YourMD Drug Database (yourmd.online). Only the drug name is transmitted — no PHI, no patient identifiers. Your allergy and health information is checked locally within the HIPAA-compliant patient record system. The drug database is a decision support tool; all prescribing decisions remain with the licensed UMG physician.

Prior Authorization

Some medications may require prior authorization (PA) from your insurer. When required, United Medical Group will determine PA requirements, submit requests containing clinically required information via HIPAA-compliant secure fax (under a signed BAA with our fax service provider), track PA status, and provide documentation for appeals. PA approval is at the insurer’s sole discretion.

Prescription Routing

Prescriptions are transmitted to compounding pharmacy partners (under executed BAAs), branded manufacturer programs (NovoCare for Novo Nordisk; LillyDirect for Eli Lilly), or retail pharmacies via our network directory.

Technology Contractor Relationship & Liability

YourMD Online, LLC operates the telehealth platform and YourMDRx as an independent technology contractor to United Medical Group, PLLC. United Medical Group is the licensed medical practice solely responsible for all clinical services, prescribing decisions, and physician-patient relationships. YourMD Online, LLC does not practice medicine. In any malpractice action, medical board proceeding, or clinical dispute, the responsible party is the treating physician and United Medical Group, PLLC. United Medical Group maintains professional liability and malpractice insurance through MagMutual. Both entities maintain cyber liability insurance covering the telehealth platform and associated data systems.

10. Limitation of Liability

11. Indemnification

To the maximum extent permitted by law, you agree to indemnify, defend, and hold harmless YourMD Online, LLC, United Medical Group, their respective parent, subsidiary, and affiliated companies, their licensed Providers, compounding-pharmacy and fulfillment partners, payment processors, and each of their officers, directors, employees, agents, contractors, successors, and assigns (collectively, "Indemnified Parties") from and against any and all claims, demands, suits, proceedings, liabilities, judgments, damages, losses, settlements, fines, penalties, costs, and expenses, including reasonable attorneys' fees and expert witness fees and court costs, arising out of or related to:

• Your access to, use of, or inability to use the platform or any Subscription Service;
• Any misrepresentation, omission, or inaccuracy in the health information, identity information, location information, or payment information you supplied;
• Your failure to disclose a contraindication, allergy, concurrent medication, pregnancy, or other material fact to your Provider;
• Any clinical outcome, adverse reaction, injury, or harm arising from medication you obtained through the platform, including harm caused by off-label use, sharing medication with third parties, or failure to follow Provider instructions;
• Any third-party claim brought by a member of your household or any other person alleging injury from medication, supplies, or devices received through your account;
• Your violation of this Agreement, the Privacy Policy, the HIPAA Notice, or any applicable federal, state, or local law or regulation;
• Your violation of any right of a third party, including intellectual property, privacy, and publicity rights;

YourMD reserves the right, at your expense, to assume the exclusive defense and control of any matter for which you are required to indemnify us, and you agree to cooperate fully in asserting any available defenses. This indemnification obligation shall survive termination of this Agreement and your use of the platform.

11A. AI Products and Clinical Decision-Support Tools

Certain AI-powered tools (including AskUnitedMedicalAI, the diagnostic companion, drug interaction checker, lab interpreter, medical dictation, and other clinical assistants) are offered by YourMD's affiliated AI-native platform at www.yourmd.online and are subject to the separate AI Terms of Service posted at that site. You acknowledge and agree that:

• AI tools are clinical decision-support only. They do not establish a provider-patient relationship, do not render a diagnosis, and do not replace the judgment of a licensed clinician.
• AI output may be incomplete, outdated, or incorrect. Providers independently verify AI-generated content before relying on it in a clinical encounter. Patients must not rely on AI tool output for self-diagnosis or self-treatment.
• Use of AI tools may involve transmission of data to the AI-native platform subject to its privacy and security controls. PHI-bearing interactions within the telehealth platform are logged in the HIPAA audit trail.
• YourMD and its affiliates disclaim all warranties and liability for AI tool accuracy, completeness, fitness for purpose, or clinical outcomes to the maximum extent permitted by law.

12. Governing Law, Arbitration, Class-Action Waiver & Fee-Shifting

This Agreement is governed by the laws of the State of Nevada, without regard to conflict-of-law principles. This arbitration agreement is governed by the Federal Arbitration Act (9 U.S.C. § 1 et seq.) which preempts any state law that would restrict or prohibit arbitration.

Any dispute, claim, or controversy arising out of or relating to this Agreement or the platform shall be resolved exclusively by final and binding individual arbitration administered by the American Arbitration Association (AAA) under its Consumer Arbitration Rules, with the seat of arbitration in Clark County, Nevada.

You and YourMD agree that each party may bring claims against the other only in an individual capacity and not as a plaintiff or class member in any purported class or representative proceeding. YOU WAIVE ANY RIGHT TO A JURY TRIAL AND TO PARTICIPATE IN A CLASS ACTION. If the class-action waiver is found unenforceable, the entire arbitration agreement shall be null and void and the dispute shall be resolved in court — but still without the right to a class action.

Filing fees: For claims of $10,000 or less, YourMD will pay all AAA administrative fees. For claims over $10,000, fees are allocated per AAA Consumer Arbitration Rules.

Fee-shifting for abusive claims: Under Nevada Revised Statutes § 18.010 and the AAA fee-shifting provisions, a party who pursues a claim without reasonable basis in law or fact — or who refuses a reasonable settlement offer and then fails to obtain a better result in arbitration — may be required to pay the other party's attorneys' fees and costs. YourMD will actively seek fee recovery in all such cases.

Opt-out: You may opt out of this arbitration agreement by sending written notice to legal@yourmd.online within 30 days of first accepting these Terms. Your notice must include your full name, email address, and a statement that you are opting out. Opting out does not affect any other term of this Agreement.

Nothing in this section prevents either party from seeking injunctive relief in a court of competent jurisdiction for intellectual property infringement or to prevent imminent harm. This arbitration agreement survives termination of your account and any clinical or purchase relationship.

13. Termination

YourMD may suspend or terminate your access to the platform at any time, with or without cause, with or without notice. Upon termination, all rights granted to you under this Agreement will cease immediately. Sections that by their nature should survive termination (including Sections 1, 4.3, 8, 10, 11, 12, and 14) shall survive.

14. Changes to This Agreement

We may amend this Agreement at any time by posting the revised version at this URL. The effective date will be updated accordingly. Continued use of the platform after changes are posted constitutes acceptance of the revised terms. For material changes, we will use reasonable efforts to notify you via email or in-app notice.

15. Severability and Entire Agreement

If any provision of this Agreement is found unenforceable, that provision shall be severed and the remaining provisions shall remain in full force and effect. This Agreement, together with the Privacy Policy, HIPAA Notice, and any applicable product-specific consents, constitutes the entire agreement between you and YourMD with respect to the subject matter herein.

16. Consent to Electronic Communications

You consent to receive communications from YourMD and your Providers electronically, including via email, SMS, and in-platform messaging. You agree that electronic signatures, consents, and records satisfy any legal requirement that such communications be in writing.

16A. Text Message (SMS) Notifications

What we send. If you request an on-demand visit and every physician licensed in your state is already with a patient, you join a virtual queue. If you have given us a mobile number and ticked the optional consent box when you made the request, we send one text message at the moment a physician becomes available for you.

How often. One message per visit request, sent only at that single moment. We do not text you about your position in the line, and we do not text you about products, offers, or promotions. These are transactional service messages about care you asked for — never marketing.

What the message contains. It does not name your physician, your reason for visiting, or any clinical information, so nothing private appears on your lock screen. It tells you your visit is ready and directs you to the patient portal, which is behind your login.

Consent is optional and costs you nothing. You choose whether to receive these texts when you provide your mobile number. If you decline, you still receive the same notification in your patient portal and by email, so you will not miss your turn. Consent applies to the visit request you made; it is not a standing subscription.

The sending number does not receive replies. Messages are sent from a toll-free number that is outbound only — nobody reads replies to it. To reach us, call 914-996-8763 or message your physician in the patient portal. Never send clinical information, symptoms, or an emergency to that number. If you are having a medical emergency, call 911.

Stopping messages. Reply STOP to any message to opt out at any time. You may also decline at the time of each request. Opting out of texts does not affect your portal or email notifications, your care, or your account.

Costs. Message and data rates may apply, depending on your mobile carrier and plan. YourMD does not charge for these messages.

Carriers. Wireless carriers are not liable for delayed or undelivered messages.

17. Contact